Clinical trial design in phase 2 and 3 trials for pulmonary hypertension
Sign Up to like & getrecommendations! Published in 2020 at "Pulmonary Circulation"
DOI: 10.1177/2045894020941491
Abstract: This article on clinical trial design incorporates the broad experience of members of the Pulmonary Vascular Research Institute’s (PVRI) Innovative Drug Development Initiative (IDDI) as an open debate platform for academia, the pharmaceutical industry and… read more here.
Keywords: trials pulmonary; clinical trial; pulmonary hypertension; design ... See more keywords
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension
Sign Up to like & getrecommendations! Published in 2020 at "Pulmonary Circulation"
DOI: 10.1177/2045894020962960
Abstract: This manuscript on endpoints incorporates the broad experience of members of Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative as an open debate platform for academia, the pharmaceutical industry and regulatory experts surrounding the future… read more here.
Keywords: trials pulmonary; clinical trials; hypertension; novel composite ... See more keywords